Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bortezomib-induced peripheral neurotoxicity: an update.
Argyriou AA, Cavaletti G, Bruna J, Kyritsis AP, Kalofonos HP. Argyriou AA, et al. Among authors: kyritsis ap. Arch Toxicol. 2014 Sep;88(9):1669-79. doi: 10.1007/s00204-014-1316-5. Epub 2014 Jul 29. Arch Toxicol. 2014. PMID: 25069804 Review.
Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells.
Alexiou GA, Gerogianni P, Vartholomatos E, Kyritsis AP. Alexiou GA, et al. Among authors: kyritsis ap. Cancer Invest. 2016 Nov 25;34(10):489-495. doi: 10.1080/07357907.2016.1233424. Epub 2016 Oct 21. Cancer Invest. 2016. PMID: 27768402
Therapeutic Hypothermia in Treating Glioblastoma: A Review.
Malliou A, Mitsiou C, Kyritsis AP, Alexiou GA. Malliou A, et al. Among authors: kyritsis ap. Ther Hypothermia Temp Manag. 2024 Mar;14(1):2-9. doi: 10.1089/ther.2023.0014. Epub 2023 May 15. Ther Hypothermia Temp Manag. 2024. PMID: 37184912 Review.
Epilepsy in the cancer patient.
Kargiotis O, Markoula S, Kyritsis AP. Kargiotis O, et al. Among authors: kyritsis ap. Cancer Chemother Pharmacol. 2011 Mar;67(3):489-501. doi: 10.1007/s00280-011-1569-0. Epub 2011 Feb 9. Cancer Chemother Pharmacol. 2011. PMID: 21305288 Review.
Prognostic significance of MRP5 immunohistochemical expression in glioblastoma.
Alexiou GA, Goussia A, Voulgaris S, Fotopoulos AD, Fotakopoulos G, Ntoulia A, Zikou A, Tsekeris P, Argyropoulou MI, Kyritsis AP. Alexiou GA, et al. Among authors: kyritsis ap. Cancer Chemother Pharmacol. 2012 May;69(5):1387-91. doi: 10.1007/s00280-012-1832-z. Epub 2012 Jan 26. Cancer Chemother Pharmacol. 2012. PMID: 22278731
In Vitro and In Vivo Preclinical Effects of Type I IFNs on Gliomas.
Galani V, Papadatos SS, Alexiou G, Galani A, Kyritsis AP. Galani V, et al. Among authors: kyritsis ap. J Interferon Cytokine Res. 2017 Apr;37(4):139-146. doi: 10.1089/jir.2016.0094. Epub 2017 Feb 17. J Interferon Cytokine Res. 2017. PMID: 28387596 Review.
Immunohistochemical study of MRP5 expression in meningiomas.
Alexiou GA, Goussia A, Ntoulia A, Zagorianakou P, Malamou-Mitsi V, Voulgaris S, Kyritsis AP. Alexiou GA, et al. Among authors: kyritsis ap. Cancer Chemother Pharmacol. 2013 Mar;71(3):825-8. doi: 10.1007/s00280-012-2057-x. Epub 2012 Dec 28. Cancer Chemother Pharmacol. 2013. PMID: 23271324
303 results